

SCOTTSDALE, Ariz., Oct. 15, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, will issue its third quarter 2026 earnings release before the market opens on Thursday, November 5, 2026.

HF Sinclair, Accenture and FirstCash post impressive gains as Zacks research portfolios highlight standout performers amid market uncertainty and shifting investor sentiment.

Nearly 3 in 4 Gen Zers Say Fear of an Unwanted Viral Moment Affects Their Mental Health, Self-Expression and Social Participation SCOTTSDALE, Ariz., Sept. 30, 2026 /PRNewswire/ -- A LifeStance Health survey released today finds that the possibility of spontaneous, authentic moments going viral on social media is affecting people's mental well-being and reshaping behavior, self-expression and participation in everyday life.

Vukasin Paunovich disposed of 42,067 shares. The transaction involved shares equal to 17% of the total stake held by the executive prior to the filing.


LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

LifeStance Health Group (NASDAQ: LFST - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Insider and Institutional Ownership 85.5% of LifeStance Health

Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.